“…Other QoL measures included the Short-Form 36 questionnaire (six RCTs), the EuroQol 5D questionnaire (four RCTs), a non-specified scale (two RCTs), the Health Utilities Mark 3 questionnaire (one RCT), the Urogenital Distress Inventory (one RCT), the Incontinence Impact Questionnaire (one RCT), the Defecation Distress Inventory (one RCT), the EuroQol Visual Analogue Scale (one RCT), the World Health Organization Quality of Life BREF Questionnaire (one RCT), patient report (one RCT), relief of symptoms on a ten-point scale (one RCT) and a five-point questionnaire (one RCT). 20,25,27,33,44,56,67,71,73,74,76,78,86,91 The median number of participants per study was 80 (IQR 70, minimum 16, maximum 384) (Table S4). The majority of trials were published in an obstetrics and gynaecology journal (34 out of 60 studies, 56.7%) with the remainder being published in specialist radiology journals (15 out of 60 studies, 25%) and general medical or surgical journals (11 out of 60 studies, 18.3%).…”